Millenium Biologix Inc.

Takeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals. In an interview with

After a period of relative quiet, Medtronic, arguably the device industry’s leading dealmaker over the past ten years, is ready to deal again. An interview with new head of corporate development, Bob

Orthobiologics are now on the horizon, driving suppliers to increase R&D spending. The goal is to develop high-margin products that will provide a scaffold for the recruitment of growth factors and ac

Healing bone better When we think of bone we sometimes think of the hard bone of a long-dead skeleton—or the big beef shinbone we give the dog for a treat. We tend to forget that bone, in life, contai